United Kingdom

Resverlogix reports $87 mln private placement with Shenzhen Hepalink

Friday, 13 Oct 2017 

Oct 13 (Reuters) - Resverlogix Corp ::Resverlogix announces $87 million private placement with shenzhen hepalink.Resverlogix Corp - ‍net proceeds of offering will primarily be used to repay company's $68.8 million secured loan which matures on December 26, 2017​.Resverlogix Corp - ‍ private placement of 60.4 million equity units to Shenzhen Hepalink Pharmaceutical Co. Ltd. At a price of $1.44 per unit​.Resverlogix-Proceeds will also be used to fund research,development activities for clinical trial activities related to phase 3 betonmace trial​.Resverlogix - ‍ placement to address co's financial difficulties by providing sufficient funds to repay loan and to satisfy short term cash requirements​. 

Company Quote

15 Jul 2019